Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works

Men at risk: occupation and male infertility.

Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · see citing works

Epidemiology, diagnosis, and management of polycystic ovary syndrome

Sirmans, S. M., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,301 · see citing works

Health effects of energy drinks on children, adolescents, and young adults

Seifert, S. M., Schaechter, J. L., Hershorin, E. R., & Lipshultz, S. E. (2011) · Pediatrics · doi:10.1542/peds.2009-3592 · Cited by 893 · see citing works

Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies

Patel, S. V., Rauf, A., Khan, H. Z., & Abu‐Izneid, T. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.091 · Cited by 630 · see citing works

Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action

Coster, S. D., & Larebeke, N. V. (2012) · Journal of Environmental and Public Health · doi:10.1155/2012/713696 · Cited by 622 · see citing works

The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?

Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592 · see citing works

Theca: the forgotten cell of the ovarian follicle

Young, J. M., & McNeilly, A. S. (2010) · Reproduction · doi:10.1530/rep-10-0094 · Cited by 516 · see citing works

C-Reactive Protein as a Marker for Inflammatory Bowel Disease

Vermeire, S., Assche, G. V., & Rutgeerts, P. J. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00026 · Cited by 514 · see citing works

Possible endocrine disrupting effects of parabens and their metabolites

Boberg, J., Taxvig, C., Christiansen, S., & Hass, U. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.03.011 · Cited by 513 · see citing works

Genetic, hormonal and metabolic aspects of PCOS: an update

De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G., & Petraglia, F. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0173-x · Cited by 484 · see citing works

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth

Rojas, J., Chávez-Castillo, M., Olivar, L. C., Rojas, M., Morillo, J., Mejias, J. A., Calvo, M. C. C., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 469 · see citing works

60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis

Grattan, D. R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0213 · Cited by 357 · see citing works

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334 · see citing works

Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease

Boulman, N., Levy, Y., Leiba, R., Shachar, S. S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 332 · see citing works

GnRH Pulsatility, the Pituitary Response and Reproductive Dysfunction

TSUTSUMI, R., & WEBSTER, N. J. G. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-185 · Cited by 317 · see citing works

Metformin: Current knowledge.

(2014) · PubMed Central · Cited by 280 · see citing works

Health risk of exposure to Bisphenol A (BPA).

Konieczna, A., Rutkowska, A. Z., & Rachoń, D. (2015) · PubMed · Cited by 269 · see citing works

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

Naderpoor, N., Shorakae, S., de Courten, B. V., Misso, M. L., Moran, L., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 256 · see citing works

Should all women with PCOS be treated for insulin resistance?

Marshall, J. C., & Dunaif, A. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 217 · see citing works

The hazardous effects of tobacco smoking on male fertility

Qiao, Z.-D., Dai, J.-B., & Wang, Z.-X. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.150847 · Cited by 212 · see citing works

Revisiting leptin’s role in obesity and weight loss

Ahima, R. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36284 · Cited by 204 · see citing works

Endocrine-disrupting Chemicals: Review of Toxicological Mechanisms Using Molecular Pathway Analysis

Yang, O., Kim, H. L., Weon, J.-I., & Seo, Y. R. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.1.12 · Cited by 197 · see citing works

Ovarian hyperstimulation syndrome

Kumar, P., Sait, S., Sharma, A., & Kumar, M. (2011) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.86080 · Cited by 192 · see citing works

Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings

Arentz, S., Abbott, J. A., Smith, C. A., & Bensoussan, A. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-511 · Cited by 191 · see citing works

Fecal calprotectin in inflammatory bowel disease

Sherwood, R. A., & Walsham, N. E. (2016) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s51902 · Cited by 183 · see citing works

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations

Zemanick, E. T., Harris, J. K., Wagner, B. D., Robertson, C. E., Sagel, S. D., Stevens, M. J., Accurso, F. J., & Laguna, T. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062917 · Cited by 180 · see citing works

Concentration of Bisphenol A in Highly Consumed Canned Foods on the U.S. Market

Noonan, G. O., Ackerman, L. K., & Begley, T. H. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf201076f · Cited by 173 · see citing works

Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism

Rajan, R. K., Siva Selva Kumar, M., & Balaji, B. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1258425 · Cited by 170 · see citing works

CD163 and its role in inflammation

Kowal, K., Silver, R., Sławińska, E., Bielecki, M., Chyczewski, L., & Kowal‐Bielecka, O. (2011) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2011.0052 · Cited by 165 · see citing works

Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes

Tal, R., Seifer, D. B., Khanimov, M., Malter, H. E., Grazi, R. V., & Leader, B. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.02.026 · Cited by 160 · see citing works

Polycystic ovary syndrome, adipose tissue and metabolic syndrome

Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159 · see citing works

Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys

Xu, N., Kwon, S., Abbott, D. H., Geller, D. H., Dumesic, D. A., Azziz, R., Guo, X., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027286 · Cited by 155 · see citing works

Endometrial progesterone resistance and PCOS

Li, X., Feng, Y., Jin-fang, L., Billig, H., & Shao, R. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-2 · Cited by 155 · see citing works

Ethnic differences in the phenotypic expression of polycystic ovary syndrome

Zhao, Y., & Qiao, J. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.006 · Cited by 152 · see citing works

Gynecomastia: Clinical evaluation and management

Polat, Ş. B., Çuhacı, N., Evranos, B., Ersoy, R., & Çakır, B. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.129104 · Cited by 146 · see citing works

A critical review on serine protease: Key immune manipulator and pathology mediator

Patel, S. V. (2017) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2016.10.011 · Cited by 146 · see citing works

Risky Health Behaviors Among Mothers-to-Be: The Impact of Adverse Childhood Experiences

Chung, E. K., Nurmohamed, L., Mathew, L., Elo, I. T., Coyne, J. C., & Culhane, J. F. (2010) · Academic Pediatrics · doi:10.1016/j.acap.2010.04.003 · Cited by 140 · see citing works

Effects of Environmental Endocrine Disruptors on Pubertal Development

Özen, S., & Darcan, Ş. (2011) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v3i1.01 · Cited by 137 · see citing works

Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome

Kokosar, M., Benrick, A., Perfilyev, A., Fornes, R., Nilsson, E., Maliqueo, M., Behre, C. J., Sazonova, A., Ohlsson, C., Ling, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22883 · Cited by 137 · see citing works

Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment

Wang, Z., Zhai, D., Zhang, D., Bai, L., Yao, R., Yu, J., Cheng, W., & Yu, C. (2016) · Reproductive Sciences · doi:10.1177/1933719116667218 · Cited by 133 · see citing works

What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis

Kulhara, P., & Gupta, S. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.58891 · Cited by 132 · see citing works

Hyperprolactinemia: pathophysiology and therapeutic approach

Capozzi, A., Scambia, G., Pontecorvi, A., & Lello, S. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1017810 · Cited by 127 · see citing works

Aromatase inhibitors for subfertile women with polycystic ovary syndrome

Franik, S., Kremer, J. A. M., Nelen, W. L. D. M., & Farquhar, C. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010287.pub2 · Cited by 125 · see citing works

Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis

Blay, S. L., de Aguiar, J. V. N. M., & Passos, I. C. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s91700 · Cited by 111 · see citing works

Amenorrhea: an approach to diagnosis and management.

Klein, D. A., & Poth, M. (2013) · PubMed · Cited by 109 · see citing works

Polycystic Ovary Syndrome and Obstructive Sleep Apnea

Tasali, E., Cauter, E. V., & Ehrmann, D. A. (2008) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.11.001 · Cited by 108 · see citing works

Longterm management of Polycystic Ovarian Syndrome (PCOS)

Bates, G. W., & Legro, R. S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.029 · Cited by 106 · see citing works

Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Peng, Z., Sun, Y., Lv, X., Zhang, H., Liu, C., & Dai, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148531 · Cited by 102 · see citing works

Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome

Kachuei, M., Jafari, F. M., Kachuei, A., & Keshteli, A. H. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2040-5 · Cited by 100 · see citing works

Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats

Jahan, S., Munir, F., Razak, S., et al. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0295-y · Cited by 95 · see citing works

miR-483–5p and miR-486–5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome

Shi, L., Liu, S., Zhao, W., & Shi, J. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.06.023 · Cited by 91 · see citing works

Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study

Tagliaferri, V., Romualdi, D., Scarinci, E., De Cicco, S., Di Florio, C., Immediata, V., Tropea, A., Santarsiero, C. M., Lanzone, A., & Apa, R. (2018) · Reproductive Sciences · doi:10.1177/1933719117711262 · Cited by 87 · see citing works

Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review

Patel, S. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.01.009 · Cited by 82 · see citing works

Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome

Stovall, D. W., Bailey, A. P., & Pastore, L. M. (2010) · Journal of Women s Health · doi:10.1089/jwh.2010.2053 · Cited by 77 · see citing works

Effects of Melatonin on Oxidative Stress Index and Alveolar Bone Loss in Diabetic Rats With Periodontitis

Köse, O., Arabacı, T., Kara, A., Yemenoğlu, H., Kermen, E., Kızıldağ, A., Gedikli, S., & Özkanlar, S. (2016) · Journal of Periodontology · doi:10.1902/jop.2016.150541 · Cited by 77 · see citing works

Anti-Müllerian hormone and polycystic ovary syndrome

Bhide, P., & Homburg, R. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.004 · Cited by 77 · see citing works

Acupuncture for polycystic ovarian syndrome

Lim, C. E. D., Ng, R. W., Xu, K., Cheng, N. C. L., Xue, C. C., Liu, J., & Chen, N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007689.pub3 · Cited by 76 · see citing works

Protective Effect of Persimmon (Diospyros kaki) Peel Proanthocyanidin against Oxidative Damage under H2O2-Induced Cellular Senescence

Lee, Y. A., Cho, E. J., & Yokozawa, T. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1265 · Cited by 75 · see citing works

Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome

Ergenoglu, M. A., Yıldırım, N., Yıldırım, A. G. Ş., Yeniel, Ö., Erbaş, O., Yavaşoğlu, A., Taşkıran, D., & Karadadaş, N. (2015) · Reproductive Sciences · doi:10.1177/1933719115570900 · Cited by 75 · see citing works

Exploring the FDA Adverse Event Reporting System to Generate Hypotheses for Monitoring of Disease Characteristics

Fang, H., Su, Z., Wang, Y., Miller, A., Liu, Z., Howard, P. C., Tong, W., & Lin, S. M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.17 · Cited by 73 · see citing works

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome

Lamos, E. M., Malek, R., & Davis, S. N. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292125 · Cited by 71 · see citing works

Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome

Mitra, S., Nayak, P., & Agrawal, S. (2015) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.149076 · Cited by 68 · see citing works

Alterations in Glucose Metabolism in Alzheimer's Disease

Calsolaro, V., & Edison, P. (2016) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214810666160615102809 · Cited by 67 · see citing works

Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management

Fader, A. N., Beavis, A., & Smith, A. J. B. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s88367 · Cited by 63 · see citing works

Prevalence of hepatic steatosis in women with polycystic ovary syndrome

Karoli, R., Fatima, J., Chandra, A., et al. (2013) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.112370 · Cited by 58 · see citing works

Serine Protease PRSS23 Is Upregulated by Estrogen Receptor α and Associated with Proliferation of Breast Cancer Cells

Hau-Shien, C., Chang, S., Wang, T., Ko, H.-J., Lin, Y.-C., Lin, K.-T., Chang, K.-M., & Chuang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030397 · Cited by 55 · see citing works

Insulin Resistance Directly Contributes to Androgenic Potential Within Ovarian Theca Cells

Qu, J., Wang, Y., Wu, X., Gao, L., Hou, L., & Erkkola, R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.167 · Cited by 51 · see citing works

Inflammasomes, the cardinal pathology mediators are activated by pathogens, allergens and mutagens: A critical review with focus on NLRP3

Patel, S. V. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.126 · Cited by 51 · see citing works

Fragrance compounds: The wolves in sheep’s clothings

Patel, S. V. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.03.025 · Cited by 50 · see citing works

Polycystic ovarian syndrome

Madnani, N., Khan, K. J., Chauhan, P. H., et al. (2013) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.110759 · Cited by 49 · see citing works

Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome

Kort, D. H., Kostolias, A., Sullivan, C., et al. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.968547 · Cited by 48 · see citing works

Association of rs10830963 and rs10830962 SNPs in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome

Li, C., Shi, Y., You, L., et al. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq087 · Cited by 43 · see citing works

Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume

Huang, R., Yue, J., Sun, Y. W., Zheng, J., Tao, T., Li, S., & Liu, W. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.015 · Cited by 42 · see citing works

Prolactin secretion in polycystic ovary syndrome (PCOS).

Szosland, K., Pawłowicz, P., & Lewiñski, A. (2015) · PubMed · Cited by 37 · see citing works

A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome

Lee, B. H., Indran, I. R., Tan, H. M., Li, Y., Zhang, Z., Li, J., & Yong, E. (2015) · Endocrinology · doi:10.1210/en.2015-1733 · Cited by 35 · see citing works

Dopamine agonist therapy in hyperprolactinemia.

Webster, J. A. (1999) · PubMed · Cited by 28 · see citing works

Serum ferritin levels and polycystic ovary syndrome in obese and nonobese women

Ko, P., Huang, S., Hsieh, C.-H., Hsu, M.-I., & Hsu, C.-S. (2015) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.06.005 · Cited by 27 · see citing works

Metformin treatment before and during in vitro fertilization or intracytoplasmic sperm injection in women with polycystic ovary syndrome: summary of a Cochrane review

Tso, L. O., Costello, M., Albuquerque, L. E. T., et al. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.038 · Cited by 26 · see citing works

Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS

Vanky, E., Kjøtrød, S., Salvesen, K. Å., Romundstad, P., Moen, M. H., & Carlsen, S. M. (2004) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2004.00373.x · Cited by 26 · see citing works

Association of Glomerular Filtration Rate with Inflammation in Polycystic Ovary Syndrome.

Gözükara, İ., Gözükara, K. H., Kucur, S. K., Karakiliç, E. Ü., Keskin, H., Akdeniz, D., Aksoy, A. N., & Çarlıoğlu, A. (2015) · PubMed Central · doi:10.22074/ijfs.2015.4238 · Cited by 25 · see citing works

Polycystic ovaries – beyond menopause

Shah, D., & Bansal, S. (2013) · Climacteric · doi:10.3109/13697137.2013.828687 · Cited by 21 · see citing works

Acanthosis nigricans: a flag for insulin resistance

Venkatswami, S., & Anandam, S. (2014) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2014.11073603 · Cited by 20 · see citing works

Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women

Roh, E. Y., Yoon, J. H., Song, E. Y., Kim, J., Hwang, K. R., Seo, S. H., & Shin, S. (2016) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0824-z · Cited by 18 · see citing works

Potent therapeutic effects of Shouwu Jiangqi Decoction (首乌僵芪汤) on polycystic ovary syndrome with insulin resistance in rats

Wang, L., Wang, X., Yu, X., & Xu, W. (2015) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-015-2147-9 · Cited by 17 · see citing works

Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic Risk

Dasanu, C. A., Clark, B. A., Ichim, T. E., & Alexandrescu, D. T. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e31820c0172 · Cited by 17 · see citing works

Stressor-driven extracellular acidosis as tumor inducer via aberrant enzyme activation: A review on the mechanisms and possible prophylaxis

Patel, S. V. (2017) · Gene · doi:10.1016/j.gene.2017.05.043 · Cited by 17 · see citing works

Deep vein thrombosis in a woman taking oral combined contraceptive pills

Piparva, K. G., & Buch, J. G. (2011) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.83284 · Cited by 16 · see citing works

Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study

Yousuf, S. D., Rashid, F., Mattoo, T., Shekhar, C., Mudassar, S., Zargar, M. A., & Ganie, M. A. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.06.010 · Cited by 16 · see citing works

The gonadotropin‐releasing hormone antagonist protocol – the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation

Kol, S., Homburg, R., Alsbjerg, B., et al. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01399.x · Cited by 15 · see citing works

Interaction of serine protease inhibitors and substrates with human uterine estrogen receptor

Lukola, A., & Punnonen, R. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)90903-2 · Cited by 15 · see citing works

Influence of chemerin rs17173608 polymorphism on polycystic ovary syndrome susceptibility

Movahed, Z. G., Kohan, L., Fallahi, S., & Tabiee, O. (2015) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.05.007 · Cited by 15 · see citing works

Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk

Wu, J. B., Zhai, J.-F., & Yang, J. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15048570 · Cited by 14 · see citing works

The effect of prolactin levels on MPV in women with PCOS

Yılmaz, Ö., Çalan, M., Küme, T., Temür, M., Yesil, P., & Senses, Y. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12647 · Cited by 13 · see citing works

MANICURISTS AND PEDICURISTS - OCCUPATION GROUP AT HIGH RISK OF WORK-RELATED DERMATOSES

Kiec-Swierczynska, M., Chomiczewska‐Skóra, D., Świerczyńska-Machura, D., et al. (2013) · Medycyna Pracy · doi:10.13075/mp.5893.2013.0052 · Cited by 13 · see citing works

Role of luteinizing hormone β-subunit gene variants among South Indian women with polycystic ovary syndrome

Dasgupta, S., Sirisha, P. V. S., Neelaveni, K., Anuradha, K., Sudhakar, G., & Reddy, B. M. (2011) · Gene · doi:10.1016/j.gene.2011.11.054 · Cited by 12 · see citing works

Extremely high levels of estradiol and testosterone in a case of polycystic ovarian syndrome. Hormone and clinical similarities with the phenotype of the α estrogen receptor null mice

Bartolone, L., Smedile, G., Arcoraci, V., et al. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343757 · Cited by 12 · see citing works

Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome

Priyadarshani, A. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345755 · Cited by 11 · see citing works

Circulating Anti-Müllerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome

Olszanecka‐Glinianowicz, M., Zachurzok, A., Drosdzol-Cop, A. B., Bożentowicz‐Wikarek, M., Owczarek, A. J., Gawlik, A., Chudek, J. T., Skrzypulec‐Plinta, V., & Małecka‐Tendera, E. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444637 · Cited by 11 · see citing works

Clomiphene for anovulatory infertility.

Davidson, R., Motan, T., & Korownyk, C. S. (2016) · PubMed · Cited by 11 · see citing works

Relationship between serum cystatin C and polycystic ovary syndrome.

Gozashti, M. H., Gholamhoseinian, A., Musavi, F., & Mashrouteh, M. (2013) · Europe PMC (PubMed Central) · Cited by 9 · see citing works

Serine Protease Inhibition Attenuates rIL-12-Induced GZMA Activity and Proinflammatory Events by Modulating the Th2 Profile From Estrogen-Treated Mice

Karpuzoglu, E., Schmiedt, C. W., Pardo, J., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1045 · Cited by 9 · see citing works

Pressure pain threshold and β-endorphins plasma level are higher in lean polycystic ovary syndrome women

Кялка, М., Milewicz, T., Mrozińska, S., Rogatko, I., Sztefko, K., & Majewska, R. (2017) · Minerva Endocrinology · doi:10.23736/s0391-1977.16.02494-9 · Cited by 9 · see citing works

Pressure pain threshold and [beta]-endorphins plasma level are higher in lean polycystic ovary syndrome women

Kialka, M., Milewicz, T., Mrozinska, S., Sztefko, K., Rogatko, I., & Majewska, R. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.41.ep751 · Cited by 6 · see citing works

[Effect of Transcutaneuos Acupoint Electrostimulation on Serum Sex Hormone Levels and Expression of Ovarian Steroid Hormone Metabolic Enzymes in Polycystic Ovary Syndrome Rats].

Zhou, J., Zhang, X., Yu, M., et al. (2016) · PubMed · Cited by 5 · see citing works

Analysis of Ebola virus polymerase domains to find strain-specific differences and to gain insight on their pathogenicity

Patel, S. V., Patel, S., Patel, S., et al. (2016) · VirusDisease · doi:10.1007/s13337-016-0334-8 · Cited by 5 · see citing works

Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome

Knebel, B., Lehr, S., Janssen, O. E., Hahn, S., Jacob, S., Nitzgen, U., Müller‐Wieland, D., & Kotzka, J. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-4080-1 · Cited by 5 · see citing works

Ghrelin imaging probe specific for prostate cancer

Clyne, M. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.93 · Cited by 3 · see citing works

Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review

He, F.-F., & Li, Y.-M. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00670-3 · Cited by 289 · see citing works

Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones—Microbiota—Inflammation Axis in Rats

Wang, T., Sha, L., Li, Y., Zhu, L., Wang, Z., Li, K., Lu, H., Bao, T., Guo, L., Zhang, X., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00284 · Cited by 162 · see citing works

The Role of Lifestyle Interventions in PCOS Management: A Systematic Review

Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115 · see citing works

The Effect of Low Carbohydrate Diet on Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials

Zhang, X., Zheng, Y., Guo, Y., & Lai, Z. (2019) · International Journal of Endocrinology · doi:10.1155/2019/4386401 · Cited by 95 · see citing works

Nutritional guidelines for the management of insulin resistance

Muscogiuri, G., Barrea, L., Caprio, M., Ceriani, F., Chavez, A. O., El Ghoch, M., Frias-Toral, E., Mehta, R. J., Mendez, V., Paschou, S. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1908223 · Cited by 63 · see citing works

Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross—Sectional study

Hasan, M., Sultana, S., Sohan, M., Parvin, S., Rahman, M. A., Hossain, M. J., Rahman, M. S., & Islam, M. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0270102 · Cited by 45 · see citing works

Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials

Lin, S., Deng, Y., Huang, J., Li, M., Sooranna, S. R., Qin, M., & Tan, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99622-4 · Cited by 35 · see citing works

Lower Fiber Consumption in Women with Polycystic Ovary Syndrome: A Meta-Analysis of Observational Studies

Leung, W. T., Tang, Z., Feng, Y., Guan, H., Huang, Z., & Zhang, W. (2022) · Nutrients · doi:10.3390/nu14245285 · Cited by 17 · see citing works

Polycystic ovary syndrome (PCOS): a cross-sectional observational study analyzing the quality of content on YouTube

Clarke, S., Jangid, G., Nasr, S., Atchade, A., Moody, B. L., & Narayan, G. (2023) · Cureus · doi:10.7759/cureus.45354 · Cited by 5 · see citing works

당뇨를 동반한 4기 대장암 환자에서 항암약물요법 반응 및 생존율에 대한 Metformin의 효과

이동준, 김번, 이진하, et al. (2012)

Metformin for Prevention of Type 2 Diabetes

Hess, A. M., & Sullivan, D. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d537 · Cited by 11 · see citing works

A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity

Aksay, E. (2007) · DergiPark (Istanbul University) · Cited by 15 · see citing works

Metformin-induced mitochondrial Complex I inhibition: facts, uncertainties, and consequences

Fontaine, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00753 · Cited by 269 · see citing works

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 246 · see citing works